The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
Blog |
The UK must act to secure the future of UK life sciences and deliver for patients
Blog |
Making Wales a destination for industry clinical trials and medical research
News |
Companies granted extension to VPAG 2026 decision deadline
News |
ABPI launches manifesto to make Scotland a leader in R&D and cutting-edge medicines
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
NICE/DSU/ABPI Masterclass: Methods for mapping health utilities for NICE submissions
NICE and the ABPI invite you to the fourth and final event in the NICE/DSU/ABPI Masterclass Programme in 2025 – Methods for mapping health utilities for NICE
ABPI Industry Summit 2025 - delivering innovation through building trust
PMCPA Code of Practice Seminar - 18 November 2025
The training will cover the requirements of the Code of Practice and procedures followed by the PMCPA, the Code of Practice Panel and the Code of Practice Appeal Board.
Online Workshop on SMC: How to prepare and submit to SMC | 08 - 09 December 2025
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]